Literature DB >> 10093009

[Laboratory diagnosis in preventive cardiology].

M Soufi1, B Noll, M Herzum, B Simon, A Steinmetz, B Maisch, J R Schaefer.   

Abstract

In recent years a large number of coronary artery disease risk factors were discovered. The knowledge of these factors improves the estimate of the coronary artery disease (CAD) risk--however it still remains to be only an "estimate". A perfect prediction of an upcoming CAD event is not possible, despite all high score laboratory technology. Therefore the use of specialized laboratory procedures should be applied carefully. Knowing the blood levels of cholesterol, triglycerides, HDL- and LDL-cholesterol and Lp(a) can be sufficient for many therapeutical decisions. Severe dyslipidemia, familial CAD and CAD without any obvious reasons demand a more specialized work-up, however, risk stratification factors such as family history, clinical history (CAD, hypertension, diabetes mellitus, smoker) and genetics are crucial, apart from the above mentioned laboratory values. Purely on the basis of the lipidologic baseline concentrations we can't give well based recommendations for the treatment of individual patients. Currently there are expert systems available which allow a risk estimate once important laboratory values (LDL cholesterol, HDL cholesterol, Triglycerides) as well as clinical data (blood pressure, family history, clinical history) are available. This system can be accessed by internet under "http:/(/)www.chd-taskforce.com".

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10093009     DOI: 10.1007/bf03043814

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  42 in total

1.  A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA.

Authors:  D S FREDRICKSON; R S LEES
Journal:  Circulation       Date:  1965-03       Impact factor: 29.690

2.  Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100.

Authors:  C Motti; H Funke; S Rust; A Dergunov; G Assmann
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

3.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels.

Authors:  J A Kuivenhoven; P de Knijff; J M Boer; H A Smalheer; G J Botma; J C Seidell; J J Kastelein; P H Pritchard
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-03       Impact factor: 8.311

5.  A specific method for the direct determination of lipoprotein cholesterol in electrophoretic patterns.

Authors:  J Aufenanger; P Haux; U Weber; R Kattermann
Journal:  Clin Chim Acta       Date:  1988-10-14       Impact factor: 3.786

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 7.  Analytical procedures for the detection and characterization of apolipoprotein E mutants.

Authors:  G Assmann; H Funke; H U Jabs
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

8.  Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.

Authors:  Y I Lolin; J E Sanderson; S K Cheng; C F Chan; C P Pang; K S Woo; J R Masarei
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

9.  Increases in serum lipid and lipoprotein levels with movement from the supine to standing position in adult men and women.

Authors:  R D Hagan; S J Upton; E V Avakian; S Grundy
Journal:  Prev Med       Date:  1986-01       Impact factor: 4.018

10.  A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.

Authors:  F Mailly; Y Tugrul; P W Reymer; T Bruin; M Seed; B F Groenemeyer; A Asplund-Carlson; D Vallance; A F Winder; G J Miller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.